WASHINGTON, March 28 (Reuters) – The chief executive of Valeant Pharmaceuticals International Inc, which is under scrutiny for dramatically hiking the price of older drugs, has been summoned to…
The post Valeant CEO subpoenaed to testify before U.S. Senate panel appeared first on NASDAQ.